<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Heska Corporation

    Heska Corporation

    Heska Corporation (NASDAQ: HSKA – News) manufactures, develops and sells advance...

    Heska Corporation (NASDAQ: HSKA – News) manuf...

    Filing Type:    PU
    TriplePulse, Inc.

    TriplePulse, Inc.

    TruBrain is a leading brand in high-performance cognitive nutrition with over $11....

    TruBrain is a leading brand in high-performance...

    Amount Raised:    $745,320.00
    Fundraising Status:    EC
    Filing Type:    CF
    MYOS RENS Technology Inc.

    MYOS RENS Technology Inc.

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a company based in Cedar Knolls, NJ was...

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a co...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc. is a biopharmaceutical company seeking to advance targe...

    AVEO Pharmaceuticals, Inc. is a biopharmaceutic...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Intellia Therapeutics, Inc.

    Intellia Therapeutics, Inc.

    Intellia Therapeutics is a leading genome editing company focused on developing cu...

    Intellia Therapeutics is a leading genome editi...

    Filing Type:    PU
    Neon Therapeutics, Inc.

    Neon Therapeutics, Inc.

    Neon Therapeutics is a clinical-stage immuno-oncology company leading in the field...

    Neon Therapeutics is a clinical-stage immuno-on...

    Filing Type:    PU
    Kezar Life Sciences, Inc.

    Kezar Life Sciences, Inc.

    Based in South San Francisco, we are a clinical-stage biotechnology company commit...

    Based in South San Francisco, we are a clinical...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.